tion was carried out in the presence of excess unlabelled hGH. The 125I-hGH bound with high affinity (Ka=0.87 \ m=+-\ 0.3 l/nmol;N=3) and the binding was time-and dosedependent. Bound 125I-hGH was displaced by rat GH and bovine GH, but not by rat prolactin. The protein was not detected in radioreceptor assay by the commonly used polyethylene glycol precipitation technique and was not recognized by a monoclonal antibody raised against lactogenic receptors from female rat liver. Covalent crosslinking of 125I-hGH to serum revealed in SDS electrophoresis two labelled complexes with molecular weights of 62 300 \m=+-\3900 and 77 600 \ m=+-\4100, respectively (N=10).
Prolactin and growth hormone are two related polypeptide hormones produced in the pituitary. After secretion into the blood they are transported to their target tissues, where they bind to specific receptors situated in the plasma membranes. The subsequent cellular transduction mechanisms are not known.
The plasma membrane receptors have been found in many tissues and species (1) and receptors from some sources as rabbit (2) and rat (3) liver have been well characterized.
Some years ago a specific GH-binding protein was identified in rabbit serum (4) . It was partially purified and characterized, and it turned out to be identical with the extracellular part of the liver re¬ ceptor (2) . Corresponding protein has also been identified in serum from man (5) and mouse (6) .
Although a substantial part (40-60%) of circulat¬ ing GH in man is bound to carrier proteins (7) , the physiological significance of such GH complexes has yet not been clarified. Binding assay by precipitation with polyethylene glycol
The assay was performed as described previously (13 mately doubled the amount of specific binding in peak I. Furthermore, one peak, comparable in size to peak I, eluted in the void volume. Since only about half of the radioactivity in this unretarded peak was specifically bound and was, moreover, as¬ sumed to be associated with aggregated molecules, the major interest was focused on the activity in peak I. That the labelled molecule in the complex in peak I (stripped serum) was intact GH was dem¬ onstrated in two different ways. Firstly, the labelled complex in peak I was, in RIA, recognized by polyclonal antibodies towards hGH (not shown). This was the case also for free hGH (peak II) but not for free I (peak III). Secondly, when material from peak I was subjected to SDS electrophoresis and the gel subsequently autoradiographed, the labelled molecules had a molecular weight of 22 kD, in agreement with the value for intact hGH ( Fig. 2) .
Chromatography on the HPLC column of the serum alone (no addition of 125I-hGH) and assays of each fraction (the HPLC assay) gave hGHbinding activity in the molecular weight range 90-115 kD (not shown).
Precipitation with PEG
Examination of fresh untreated serum for hGHbinding, using the PEG precipitation assay, gave no detectable activity. However, assays of stripped serum (50 nl), performed in the same way gave binding activity at a significant level (7.8 ± 1.4%; N=8;). By applying stripped serum to the agarose HPLC column and examining the eluates, the PEG precipitable hGH-binding activity was located in the void volume peak. In contrast, the activity in peak I was not precipitated by PEG (Fig. 3) and on the incubation time (Fig. 4) hGH during incubations with 125I-hGH eliminated the two bands from the autoradiograms (lane c).
Cross-linking of 125I-hGH to fractions obtained by the HPLC of stripped serum and subsequent electrophoresis showed the same two bands in lanes where samples from peak I were applied (Fig. 5 , lane e), but not in lanes which contained samples from other fractions, including samples from the void volume peak. Cross-linked complexes origi¬ nating from this peak were not able to enter the separation gel (Fig. 5, lane d (18) , it follows that less than 10% of circulating rGH can be bound. Labelled hormone incu¬ bated in a serum-containing medium may be de¬ graded. Therefore, it was important to show that the labelled complex in peak I contained intact GH.
The transference of the labelled component to anti-hGH is supporting evidence that the hormone was not degraded and also suggests that the specific binding calculated was not due to incubation damage described in connection with RIA (19, 20 Similarly to the binding proteins from rabbit (5) and mouse serum (6) , the protein from rat serum showed specificity towards somatogenic hormones. The small amount of labelled hGH displaced by rPRL can most probably be attributed to trace amounts of rGH in the PRL preparation used and consequently does not reflect a specificity of the binding proteins for lactogenic hormones. In the rabbit, the binding protein has been shown to be identical to the extracellular part of the liver re¬ ceptor (2) . In the rat, the difference in specificity between the binding protein in serum and that of the predominating liver receptor, which is lactoge¬ nic (11) 
